Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
Agnese Gugliandolo, Federica Pollastro, Gianpaolo Grassi, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 1992-1992
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
Federica Pellati, Vittoria Borgonetti, Virginia Brighenti, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-15
Open Access | Times Cited: 315
The Neurotherapeutic Arsenal in Cannabis sativa: Insights into Anti-Neuroinflammatory and Neuroprotective Activity and Potential Entourage Effects
Ahmad K. Al-Khazaleh, Xian Zhou, Deep Jyoti Bhuyan, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 410-410
Open Access | Times Cited: 28
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
Tommaso Cassano, Rosanna Villani, Lorenzo Pace, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 120
The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies
Frances Henshaw, Lauren S. Dewsbury, Chai K. Lim, et al.
Cannabis and Cannabinoid Research (2021) Vol. 6, Iss. 3, pp. 177-195
Open Access | Times Cited: 105
Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
Kenneth B. Walsh, Amanda E. McKinney, Andrea E. Holmes
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 99
Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes
Viviana di Giacomo, Annalisa Chiavaroli, Lucia Recinella, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3575-3575
Open Access | Times Cited: 90
A systematic review of minor phytocannabinoids with promising neuroprotective potential
Nicole L. Stone, Alexandra J. Murphy, Timothy J. England, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 19, pp. 4330-4352
Open Access | Times Cited: 86
Plant Natural Products for Human Health
Chun-Tao Che, Hongjie Zhang
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 830-830
Open Access | Times Cited: 80
Constituents of Cannabis Sativa
Erin M. Rock, Linda A. Parker
Advances in experimental medicine and biology (2020), pp. 1-13
Closed Access | Times Cited: 80
Cannabis sativa L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment
Anna Stasiłowicz-Krzemień, Anna Tomala, Irma Podolak, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 778-778
Open Access | Times Cited: 76
Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia
Sachiko Koyama, Kenji Kondo, Rumi Ueha, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8912-8912
Open Access | Times Cited: 63
The Origin and Biomedical Relevance of Cannabigerol
Anna Jastrząb, Iwona Jarocka-Karpowicz, Elżbieta Skrzydlewska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7929-7929
Open Access | Times Cited: 57
Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives
Fabrizio Calapai, Luigi Cardia, Emanuela Esposito, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 43
Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota
Mariana Veiga, Manuela Amorim, Inês Pinto-Ribeiro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2389-2389
Open Access | Times Cited: 31
Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
Santa Mammana, Eugenio Cavalli, Agnese Gugliandolo, et al.
Medicina (2019) Vol. 55, Iss. 11, pp. 747-747
Open Access | Times Cited: 74
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
Leontina Elena Filipiuc, Daniela Carmen Ababei, Teodora Alexa‐Stratulat, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1823-1823
Open Access | Times Cited: 56
Phytocannabinoid Pharmacology: Medicinal Properties of Cannabis sativa Constituents Aside from the “Big Two”
Peter B. Sampson
Journal of Natural Products (2020) Vol. 84, Iss. 1, pp. 142-160
Closed Access | Times Cited: 51
Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action
Seegehalli M. Anil, Hadar Peeri, Hinanit Koltai
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy
Lara Senn, Giuseppe Cannazza, Giuseppe Biagini
Pharmaceuticals (2020) Vol. 13, Iss. 8, pp. 174-174
Open Access | Times Cited: 44
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids
Rafael Franco, Rafael Rivas‐Santisteban, Irene Reyes‐Resina, et al.
Pharmacological Research (2020) Vol. 158, pp. 104801-104801
Closed Access | Times Cited: 40
Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots
Dan Jin, Philippe Henry, Jacqueline J. Shan, et al.
Frontiers in Plant Science (2021) Vol. 12
Open Access | Times Cited: 36
Cannabigerol: a bibliometric overview and review of research on an important phytocannabinoid
Chinedu P. Anokwuru, Felix L. Makolo, Maxleene Sandasi, et al.
Phytochemistry Reviews (2022) Vol. 21, Iss. 5, pp. 1523-1547
Closed Access | Times Cited: 24
Hemp microgreens as an innovative functional food: Variation in the organic acids, amino acids, polyphenols, and cannabinoids composition of six hemp cultivars
Antonio Pannico, Marios C. Kyriacou, Christophe El‐Nakhel, et al.
Food Research International (2022) Vol. 161, pp. 111863-111863
Closed Access | Times Cited: 23
Evaluation of the anti-inflammatory effects of selected cannabinoids and terpenes from Cannabis Sativa employing human primary leukocytes
Lance K. Blevins, Anthony Bach, Robert B. Crawford, et al.
Food and Chemical Toxicology (2022) Vol. 170, pp. 113458-113458
Closed Access | Times Cited: 21
Cannabinoids and terpenes for diabetes mellitus and its complications: from mechanisms to new therapies
Esmaeel Ghasemi-Gojani, Igor Kovalchuk, Olga Kovalchuk
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 12, pp. 828-849
Closed Access | Times Cited: 21
Page 1 - Next Page

Scroll to top